BUSINESS
F&O Manual: Nifty pulls back but traders remain cautious
The Nifty failed to sustain its attempts at a rebound twice in the past two weeks, making traders sceptical of the recovery. Sectoral indices were showing a mixed trend in the morning trade
BUSINESS
F&O Manual: Analysts see chances of Nifty bouncing back
The US and Asian markets also remained weak on the back of persisting worries over the health of the global banking system.
BUSINESS
F&O Manual: Bearish sentiment to continue as setup remains weak
After a weak start, the market saw high volatility. Mid-afternoon gains were squandered in selling in the final hours with the benchmarks indices ending the day on a losing note
BUSINESS
F&O Manual: Traders expect some gains as day progresses
Global markets declined after the US Federal Reserve raised interest rates by 25 basis points, even as banking sector concerns weigh heavy
BUSINESS
F&O Manual: Trade to hinge on FOMC outcome tomorrow, initiate non-directional strategy, say analysts
"Even though the market has priced in 25 bps rate hike, any negative commentary from Fed chair Jerome Powell can trigger selling," says Viraj Vyas of Ashika Stock Broking.
BUSINESS
CLSA's ratings upgrades trigger gains in life insurance stocks
Life insurance stocks have experienced a correction ranging from 7-24 percent since the budget.
BUSINESS
F&O Manual | Analysts foresee tepid trading as investors take cautious steps
A clear directional move in the market is unlikely before the release of the Federal Reserve's monetary policy decision, due later today.
BUSINESS
F&O Manual: Recovery may continue tomorrow, analysts suggest buy on dips
Recovery in the market was driven by gains across financial names and heavyweights like Reliance Industries and Bajaj Finance.
BUSINESS
Dr Lal Pathlabs will sustain pre-COVID margins, says brokerage firm JM Financial
JM Financial foresees acquisitions coming in for Dr Lal Pathlabs in FY24 to drive inorganic growth as the company has sufficient net cash flows on its balancesheet.
BUSINESS
F&O Manual | Call writers pile up at 17,200, traders wait for a breakout
Traders expect upside momentum to catch up once the Nifty surpasses 17,150-17,200 zone.
BUSINESS
Brokerage firm Nirmal Bang sees favourable risk-reward in pharma
Pharma companies are likely to experience a recovery in margins, thanks to the easing of raw material costs and a reduction in price erosion in the US market.
BUSINESS
F&O Manual: Analysts suggest to wait for pullback as setup remains bearish
All sectoral indices, except telecom were swamped by strong selling pressures.
BUSINESS
Divi's Labs set for big margin boost but valuations expensive, says MOFSL
The capital expenditure of Rs 2,800 crore incurred at its existing sites would cater to the pharma company’s growth over the next 12-24 months, while the spend at the Kakinada unit would drive growth beyond FY25, the brokerage firm has said
BUSINESS
F&O Manual: Nifty slides, traders expect more weakness as day progresses
The Nifty snapped a two-day modest recovery as weak global cues dented sentiment. Most sectoral indices mirrored the Nifty and were trading low in the morning
BUSINESS
F&O Manual: Nifty gains but traders expect range-bound movement as day progresses
Buying from lower levels and positive global cues helped lift sentiment for domestic equities today.
BUSINESS
Why HDFC Securities is bullish on this smallcap pharma stock?
In November 2022, HDFC Securities initiated coverage on this pharma stock with a buy rating with a bull case target of Rs 66.60, which it achieved in January
BUSINESS
F&O Manual; Nifty likely to consolidate, add fresh shorts after some pullback, say analysts
No substantial short covering happened in today's trade which suggests sentiment will remain "sell on rise", said Rajesh Palviya of Axis Securities.
BUSINESS
FTSE, S&P BSE's B-22 rebalance expected to attract $450m inflow
The rebalancing of FTSE's All World All Cap and S&P BSE's Bharat 22 indices will happen on March 17 and the changes will come into effect on March 20.
BUSINESS
IndusInd Bank shares tumble 3% post large deal
The stock has corrected around 13 percent in the past week.
BUSINESS
DLF shares zoom as realtor clocks in Rs 8,000 cr in pre-sales for Gurgaon luxury project
The real estate developer's residential business had also delivered 24 percent year-on-year growth in the third quarter.
BUSINESS
F&O Manual: Momentum to remain weak as volatility runs high
The Nifty is seen in a narrow range through the session as momentum remains weak.
BUSINESS
F&O Manual: Traders suggest to go short as momentum remains weak
The Nifty extended losses to the fifth session and ended below the crucial 17,000 mark on March 15.
BUSINESS
Channel checks by ICICI Securities reflect mixed price, volume trends for Specialty Chemcials cos in January
ICICI Securities has a "buy" rating on Gujarat Fluorochemicals, Archean Chemical, Tatva Chintan, EPL, Chemplast Sanmar, PCBL in the specialty chemicals basket, along with a "hold" call for industry leader SRF.
BUSINESS
Cipla shares gain as co to sell majority stake in Uganda subsidiary
With the stake sale, CQCIL will cease to be a subsidiary of Cipla.
